pharmacovigil diversement pharmacolog pharmaci healthcar qualiti pharmacovigil pv pharmacolog scienc relat detect assess understand prevent advers particularli long term short term side medicin gener speak pharmacovigil scienc collect monitor assess evalu inform healthcar provid patient advers medic biolog product herbal tradit medicin view identifi inform hazard associ medicin prevent harm patient etymolog root pharmakon greek drug vigilar latin awak alert watch pharmacovigil particularli concern advers drug reaction adr offici describ respons drug noxiou unintend occur dose normal used prophylaxi diagnosi therapi diseas modif physiolog function pharmacovigil gain import doctor scientist number stori mass media drug recal increas becaus clinic trial involv sever patient common side adr unknown time drug enter market veri sever adr liver damag undetect becaus studi popul small postmarket pharmacovigil tool data mine investig case report identifi relationship drug adr risk medicin medicin help bring improv health longer life human medicin affect live hundr peopl everi day risk caus caus will continu caus harm mani peopl larg number peopl experi evid drug risk medic treatment medicin led major improv treatment control diseas produc advers human bodi time time mani drug precis target caus mechan diseas minor distress bodi interact neg system individu drug substanc work well mani thing safe drug risk ani intrus human bodi chemic surgic noth thi field entir predict interact scienc human bodi produc surpris term commonli drug safeti benefit commonli express proven therapeut good product includ patient subject assess risk probabl harm caus usual express percent ratio treat popul probabl occurr harm natur extent actual damag caus confus risk express extent drug work real circumst ie clinic practic clinic trial efficaci express extent drug work ideal circumst ie clinic trial find risk drug pharmaceut compani requir law countri perform clinic trial test drug peopl befor gener avail manufactur agent usual select repres sampl patient drug design compar control group control group receiv placebo andor anoth drug alreadi market diseas purpos clinic trial discov drug work well ha ani harm benefitharmrisk profil doe good harm ha potenti harm probabl seriou harm clinic trial gener good deal well drug work potenti harm caus provid inform reliabl larger popul characterist trial group age gender health ethnic origin variabl clinic trial specifi control result relat onli popul trial group repres sampl clinic trial stori drug situat fact noth stori clinic trial determin legisl contemporari judgement accept balanc benefit harm spontan report spontan report core datagener system intern pharmacovigil reli healthcar profession place consum identifi report ani suspect advers drug reaction nation pharmacovigil centr manufactur spontan report alway submit voluntarili thi system major weak underreport figur vari greatli countri relat minor seriou adr anoth problem overwork medic personnel alway report prioriti symptom seriou notic symptom seriou recognis drug spontan report crucial element worldwid enterpris pharmacovigil form core health organ databas includ report septemb grow annual report method countri legal oblig spontan report physician countri manufactur requir submit report receiv healthcar provid nation author intens focus programm concentr drug controversi drug prescrib habit group doctor involv pharmacist report gener potenti inform intens scheme howev tend intern collabor principl intern collabor field pharmacovigil princip basi intern drug monitor programm member nation system place encourag healthcar personnel record report advers drug patient report assess local lead action countri membership programm countri report elsewher european union ha scheme member countri send report uppsala monitor centr process evalu enter intern databas sever report advers reaction drug thi process lead detect signal alert possibl hazard commun member countri thi happen onli detail evalu expert review pharmacovigil europ pharmacovigil effort europ coordin european medicin agenc emea conduct nation compet medicin author nca main respons emea maintain develop pharmacovigil databas consist suspect seriou advers reaction medicin observ european commun system call eudravigil separ databas human veterinari reaction europ requir individu market authoris holder drug compani submit receiv advers reaction electron form save circumst report oblig variou stakehold defin commun legisl regul ec human medicin european union direct amend direct veterinari medicin direct amend report commerci softwar develop purpos web util call evweb access eudravigil homepag registr evweb necessari pharmacovigil unit us drug regul prescript drug overthecount drug law feder food drug cosmet comprehens drug abus prevent control control substanc prescript drug market drug price competit patent term restor hatchwaxman exempt govern agenc unit depart health human servic food drug administr drug enforc administr nation institut health center drug evalu process drug develop drug applic investig drug clinic trial phase ii iii iv random control trial pharmacovigil abbrevi drug applic fast track approv intern coordin intern confer harmonis technic requir registr pharmaceut human uppsala monitor centr health organ council intern organ medic scienc singl convent narcot drug nongovernment organ institut medicin advers drug event report three primari branch pharmacovigil us includ fda pharmaceut manufactur academicnonprofit organ radar public citizen risk manag head medicin agenc http headsmedagenciesorg agre mandat ad hoc work group establish european risk manag strategi work group consid conduct high level survey eu pharmacovigil resourc promot utilis expertis encourag collabor work refer sourc import pharmacovigil technic report advers drug reaction advers medicin american societi consult pharmacist american societi medic safeti offic boston collabor drug surveil program consult pharmacist costart code symbol thesauru advers reaction term eudravigil intern societi pharmacoepidemiolog meddra medic dictionari regulatori activ nation drug safeti leagu public health pharmacoepidemiolog pharmacotherapi intern societi pharmacovigil therapeut risk manag uppsala monitor centr unicu regulatori servic whoart yellow card scheme uk druglog metricstream extern link current problem pharmacovigil unit fda guidanc good pharmacovigil practic